List of insiders holdings for Axsome Therapeutics, Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
| Insider Holder Name | Report Date Time | Shares Owned Directly | Shares Owned Indirectly | Total Shares Owned | Market Value | Shares Changed Vs. Prev Report | Filing |
| Antecip Capital LLC 10% Owner | 2015-12-04 16:52:32 | 7,344,500 | 0 | 7,344,500 | $199,660,233 | 7,344,500 (New Position) | Form 13D |
| Kaye Randall Chief Medical Officer | 2015-12-24 13:02:23 | 0 | 6022 | 6022 | $163,708 | 1000 (19.91%) | Form 4 |
| Ames Constance VP | 2017-03-17 17:00:08 | 25,000 | 0 | 25,000 | $679,625 | 0 (Unchanged) | Form 4 |
| Golubieski John CFO | 2017-08-08 16:25:42 | 132,000 | 0 | 132,000 | $3,588,420 | 132,000 (New Position) | Form 4 |
| POTTER MYRTLE S Director | 2019-06-10 18:20:59 | 13,000 | 0 | 13,000 | $353,405 | -4000 (-23.53%)  | Form 4 |
| Marek David C Chief Commercial Officer | 2020-03-19 21:19:02 | 70,517 | 0 | 70,517 | $1,917,005 | 44,704 (173.18%) | Form 4 |
| TABUTEAU HERRIOT CEO 10% Owner | 2021-03-09 21:45:55 | 148,870 | 0 | 148,870 | $4,047,031 | -71,597 (-32.48%) | Form 4 |
| Jacobson Mark L. COO | 2021-11-15 19:54:01 | 41,638 | 0 | 41,638 | $1,131,929 | -22,163 (-34.74%) | Form 4 |
| Saad Mark E Director | 2021-11-19 07:30:28 | 10,002 | 100 | 10,102 | $274,623 | 2777 (37.91%) | Form 4 |
| Coleman Mark Director | 2021-11-22 07:30:39 | 4100 | 422,428 | 426,528 | $11,595,164 | 419,203 (5722.91%) | Form 4 |
| Pizzie Nick CFO | 2021-11-22 07:31:17 | 41,789 | 142 | 41,931 | $1,139,894 | 5845 (16.20%) | Form 4 |
| JEFFS ROGER Director | 2021-11-23 07:30:09 | 120,756 | 46,912 | 167,668 | $4,558,055 | 160,343 (2188.98%) | Form 4 |